Cargando…

Reduced Cross-Sectional Muscle Growth Six Months after Botulinum Toxin Type-A Injection in Children with Spastic Cerebral Palsy

Botulinum Neurotoxin type-A (BoNT-A) injections are widely used as first-line spasticity treatment in spastic cerebral palsy (SCP). Despite improved clinical outcomes, concerns regarding harmful effects on muscle morphology have been raised. Yet, the risk of initiating BoNT-A to reduce muscle growth...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Beukelaer, Nathalie, Weide, Guido, Huyghe, Ester, Vandekerckhove, Ines, Hanssen, Britta, Peeters, Nicky, Uytterhoeven, Julie, Deschrevel, Jorieke, Maes, Karen, Corvelyn, Marlies, Costamagna, Domiziana, Gayan-Ramirez, Ghislaine, Van Campenhout, Anja, Desloovere, Kaat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876834/ https://www.ncbi.nlm.nih.gov/pubmed/35202166 http://dx.doi.org/10.3390/toxins14020139

Ejemplares similares

Botulinum Toxin Treatment of Adult Muscle Stem Cells from Children with Cerebral Palsy and hiPSC-Derived Neuromuscular Junctions
por: Costamagna, Domiziana, et al.
Publicado: (2023)

Muscle Microbiopsy to Delineate Stem Cell Involvement in Young Patients: A Novel Approach for Children With Cerebral Palsy
por: Corvelyn, Marlies, et al.
Publicado: (2020)

Fine-needle percutaneous muscle microbiopsy technique as a feasible tool to address histological analysis in young children with cerebral palsy and age-matched typically developing children
por: Deschrevel, Jorieke, et al.
Publicado: (2023)

Morphological Medial Gastrocnemius Muscle Growth in Ambulant Children with Spastic Cerebral Palsy: A Prospective Longitudinal Study
por: De Beukelaer, Nathalie, et al.
Publicado: (2023)

Muscle Characteristics in Pediatric Hereditary Spastic Paraplegia vs. Bilateral Spastic Cerebral Palsy: An Exploratory Study
por: De Beukelaer, Nathalie, et al.
Publicado: (2021)

The Short-Term Impact of Botulinum Neurotoxin-A on Muscle Morphology and Gait in Children with Spastic Cerebral Palsy
por: Peeters, Nicky, et al.
Publicado: (2022)

The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy
por: Hanssen, Britta, et al.
Publicado: (2021)

The Myotube Analyzer: how to assess myogenic features in muscle stem cells
por: Noë, Simon, et al.
Publicado: (2022)

Joint and Muscle Assessments of the Separate Effects of Botulinum NeuroToxin-A and Lower-Leg Casting in Children With Cerebral Palsy
por: Peeters, Nicky, et al.
Publicado: (2020)

Autologous iPSC-Derived Human Neuromuscular Junction to Model the Pathophysiology of Hereditary Spastic Paraplegia
por: Costamagna, Domiziana, et al.
Publicado: (2022)

Progressive resistance training for children with cerebral palsy: A randomized controlled trial evaluating the effects on muscle strength and morphology
por: Hanssen, Britta, et al.
Publicado: (2022)

Structural Brain Lesions and Gait Pathology in Children With Spastic Cerebral Palsy
por: Papageorgiou, Eirini, et al.
Publicado: (2020)

Instrumented strength assessment in typically developing children and children with a neural or neuromuscular disorder: A reliability, validity and responsiveness study
por: Verreydt, Ineke, et al.
Publicado: (2022)

Spasticity and Its Contribution to Hypertonia in Cerebral Palsy
por: Bar-On, Lynn, et al.
Publicado: (2015)

Are spasticity, weakness, selectivity, and passive range of motion related to gait deviations in children with spastic cerebral palsy? A statistical parametric mapping study
por: Papageorgiou, Eirini, et al.
Publicado: (2019)

Movement History Influences Pendulum Test Kinematics in Children With Spastic Cerebral Palsy
por: Willaert, Jente, et al.
Publicado: (2020)

Treatment Response to Botulinum Neurotoxin-A in Children With Cerebral Palsy Categorized by the Type of Stretch Reflex Muscle Activation
por: Bar-On, Lynn, et al.
Publicado: (2020)

Reduced reciprocal inhibition during clinical tests of spasticity is associated with impaired reactive standing balance control in children with cerebral palsy
por: Willaert, Jente, et al.
Publicado: (2023)

Muscle weakness has a limited effect on motor control of gait in Duchenne muscular dystrophy
por: Vandekerckhove, Ines, et al.
Publicado: (2020)

Muscle synergy structure and gait patterns in children with spastic cerebral palsy
por: Goudriaan, Marije, et al.
Publicado: (2021)

Applying Stretch to Evoke Hyperreflexia in Spasticity Testing: Velocity vs. Acceleration
por: Sloot, Lizeth H., et al.
Publicado: (2021)

Longitudinal Alterations in Gait Features in Growing Children With Duchenne Muscular Dystrophy
por: Vandekerckhove, Ines, et al.
Publicado: (2022)

Muscle Activation Patterns When Passively Stretching Spastic Lower Limb Muscles of Children with Cerebral Palsy
por: Bar-On, Lynn, et al.
Publicado: (2014)

The Intra- and Inter-Rater Reliability of an Instrumented Spasticity Assessment in Children with Cerebral Palsy
por: Schless, Simon-Henri, et al.
Publicado: (2015)

Neuro-musculoskeletal simulation of instrumented contracture and spasticity assessment in children with cerebral palsy
por: van der Krogt, Marjolein Margaretha, et al.
Publicado: (2016)

Comprehensive evaluation of gait, spasticity, and muscle morphology: A case report of a child with spastic paresis treated with Botulinum NeuroToxin‐A, serial casting, and physiotherapy
por: Weide, Guido, et al.
Publicado: (2019)

Human iPSC model reveals a central role for NOX4 and oxidative stress in Duchenne cardiomyopathy
por: Duelen, Robin, et al.
Publicado: (2022)

A spasticity model based on feedback from muscle force explains muscle activity during passive stretches and gait in children with cerebral palsy
por: Falisse, Antoine, et al.
Publicado: (2018)

The Central Effects of Botulinum Toxin in Dystonia and Spasticity
por: Hok, Pavel, et al.
Publicado: (2021)

Intensive Therapy of the Lower Limbs and the Trunk in Children with Bilateral Spastic Cerebral Palsy: Comparing a Qualitative Functional and a Functional Approach
por: van Tittelboom, Vanessa, et al.
Publicado: (2023)

Literature Review and Comparison of Two Statistical Methods to Evaluate the Effect of Botulinum Toxin Treatment on Gait in Children with Cerebral Palsy
por: Nieuwenhuys, Angela, et al.
Publicado: (2016)

The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia
por: Chen, Yen-Ting, et al.
Publicado: (2020)

Guidelines for the use of botulinum toxin in movement disorders and spasticity
por: Jabeen, Afshan, et al.
Publicado: (2011)

Prevalence of Joint Gait Patterns Defined by a Delphi Consensus Study Is Related to Gross Motor Function, Topographical Classification, Weakness, and Spasticity, in Children with Cerebral Palsy
por: Nieuwenhuys, Angela, et al.
Publicado: (2017)

Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy
por: Pavone, Vito, et al.
Publicado: (2016)

Effect of botulinum toxin type-A in patients with focal spasticity
por: Selimoglu, Esra, et al.
Publicado: (2015)

Spasticity treatment with botulinum toxin during the COVID-19 pandemic
por: Branquinho, Lurdes Rovisco, et al.
Publicado: (2021)

Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis
por: Novarella, Federica, et al.
Publicado: (2022)

Reliability of Isokinetic Strength Assessments of Knee and Hip Using the Biodex System 4 Dynamometer and Associations With Functional Strength in Healthy Children
por: van Tittelboom, Vanessa, et al.
Publicado: (2022)

Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity
por: Kaku, Michelle, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0gic2v78qfhdicceeej29qgt8e